Retinitis Pigmentosa (RP) Active Not Recruiting Phase 2 Trials for Aflibercept (DB08885)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02661711Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) StudyTreatment